These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3622862)

  • 1. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. II. PSL pharmacokinetics during intermittent treatment with PSL administration 4 consecutive days a week].
    Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1987 May; 63(5):675-94. PubMed ID: 3622862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. I. PSL pharmacokinetics during daily PSL treatment].
    Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):697-712. PubMed ID: 3758429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of plasma total and free prednisolone during an alternate-day regimen.
    Fuwa Y; Yasuda K; Adachi K; Goshima E; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1991 Jan; 67(1):8-22. PubMed ID: 2013347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the pharmacokinetics of plasma total and free prednisolone during daily and intermittent regimens.
    Yasuda K; Goshima E; Adachi K; Fuwa Y; Yamakita N; Miura K
    J Clin Endocrinol Metab; 1990 Apr; 70(4):957-64. PubMed ID: 2318951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined effect of cyclosporin and prednisolone for minimal change nephrotic syndrome: comparison with prednisolone therapy].
    Hayashi M; Kimura N; Fukatsu A
    Nihon Jinzo Gakkai Shi; 2008; 50(5):581-7. PubMed ID: 18767486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone.
    Chen MF; Shimada F; Kato H; Yano S; Kanaoka M
    Endocrinol Jpn; 1991 Apr; 38(2):167-74. PubMed ID: 1752235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate.
    Chen MF; Shimada F; Kato H; Yano S; Kanaoka M
    Endocrinol Jpn; 1990 Jun; 37(3):331-41. PubMed ID: 2253583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
    Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between pulsed high-dose dexamethasone and daily corticosteroid therapy for adult primary immune thrombocytopenia: a retrospective study.
    Nakazaki K; Hosoi M; Hangaishi A; Ichikawa M; Nannya Y; Kurokawa M
    Intern Med; 2012; 51(8):859-63. PubMed ID: 22504239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.
    Ueda N; Chihara M; Kawaguchi S; Niinomi Y; Nonoda T; Matsumoto J; Ohnishi M; Yasaki T
    J Pediatr; 1988 Jan; 112(1):122-6. PubMed ID: 3335948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of a 3 day course with a 2 week course of oral prednisolone in patients with chronic asthma].
    Hasegawa T; Ishihara K; Fujii H; Nishimura T; Umeda B
    Arerugi; 1998 May; 47(5):543-9. PubMed ID: 9656577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan.
    Kubota S; Nishihara E; Kudo T; Ito M; Amino N; Miyauchi A
    Thyroid; 2013 Mar; 23(3):269-72. PubMed ID: 23227861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Discontinuation of Prednisolone Therapy on Risk of Cardiac Mortality Associated With Worsening Left Ventricular Dysfunction in Cardiac Sarcoidosis.
    Nagai T; Nagano N; Sugano Y; Asaumi Y; Aiba T; Kanzaki H; Kusano K; Noguchi T; Yasuda S; Ogawa H; Anzai T
    Am J Cardiol; 2016 Mar; 117(6):966-71. PubMed ID: 26805658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis.
    Arao T; Okada Y; Torimoto K; Kurozumi A; Narisawa M; Yamamoto S; Tanaka Y
    J UOEH; 2015 Jun; 37(2):103-10. PubMed ID: 26073499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.
    Bergrem H; Grøttum P; Rugstad HE
    Eur J Clin Pharmacol; 1983; 24(3):415-9. PubMed ID: 6861855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
    Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
    Intern Med; 2019 May; 58(9):1257-1262. PubMed ID: 30626831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative.
    Pagani O; Zucchetti M; Sessa C; de Jong J; D'Incalci M; De Fusco M; Kaeser-Fröhlich A; Hanauske A; Cavalli F
    Cancer Chemother Pharmacol; 1996; 38(6):541-7. PubMed ID: 8823496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
    Lima DR; Santos RM; Werneck E; Andrade GN
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.